Venetoclax: How Does It Work?

http://youtu.be/0t5POVURJqA Why hasn’t venetoclax (Venclexta) been approved as a front-line therapy for CLL? CLL experts, Dr. Nicole Lamanna and Dr. Michael Keating explain the mechanism behind venetoclax, offering insight into the behavior of this therapy and explaining the need for continued clinical trials. Get email alerts | http://www.patientpower.info/alerts Subscribe on YouTube | http://www.youtube.com/patientpower Like on Facebook | http://www.fb.com/patientpower.info Follow on Twitter | http://www.twitter.com/patientpower Follow on Google+ | http://www.google.com/+patientpowerinfo